logo

Vbi Vaccines Inc. (VBIV)



Trade VBIV now with
  Date
  Headline
8/2/2021 8:05:23 AM VBI Vaccines Q2 Loss/shr $0.07 Vs. Loss/shr $0.04 Last Year
6/23/2021 7:18:35 AM Brii Biosciences, VBI Vaccines Present Positive Data From Phase 1b/2a Study On VBI-2601 In Chronic Hepatitis B At ILC
6/9/2021 8:30:28 AM VBI Vaccines Announces Multiple Abstracts Accepted For Poster Presentations At EASL
6/8/2021 8:10:10 AM VBI Vaccines Granted FDA Fast Track Designation For VBI-1901 For Recurrent GBM Patients With First Tumor Recurrence
5/21/2021 8:09:15 AM VBI Vaccines Agrees To Drawdown $12 Mln Second Tranche Under Debt Financing Facility With K2 Health Ventures
5/12/2021 8:42:59 AM VBI Vaccines Reports Publication Of Results From Pivotal Phase 3 Study, PROTECT
5/10/2021 8:30:55 AM VBI Vaccines Q1 Loss/Shr $0.07 Vs Loss $0.05 Last Year
4/28/2021 8:50:49 AM VBI Announces Publication Of Preclinical And Challenge Study Data Of EVLP Vaccine Candidate Against COVID-19
4/21/2021 8:12:59 AM Brii Biosciences, Vir Biotechnology, VBI Vaccines Begin Phase 2 Clinical Trial Of BRII-835 In Combination With BRII-179
4/12/2021 8:18:34 AM VBI Vaccines Announces Phase 1b/2a Data And Progress Of Hepatitis B Immunotherapeutic Candidate